Your browser doesn't support javascript.
loading
Inorganic nanoparticle-integrated mesenchymal stem cells: A potential biological agent for multifaceted applications.
Zheng, Juan-Juan; Jiang, Xin-Chi; Li, Yao-Sheng; Gao, Jian-Qing.
Afiliação
  • Zheng JJ; Institute of Pharmaceutics College of Pharmaceutical Sciences Zhejiang University Hangzhou China.
  • Jiang XC; Institute of Pharmaceutics College of Pharmaceutical Sciences Zhejiang University Hangzhou China.
  • Li YS; Institute of Pharmaceutics College of Pharmaceutical Sciences Zhejiang University Hangzhou China.
  • Gao JQ; Institute of Pharmaceutics College of Pharmaceutical Sciences Zhejiang University Hangzhou China.
MedComm (2020) ; 4(4): e313, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37533768
ABSTRACT
Mesenchymal stem cell (MSC)-based therapies are flourishing. MSCs could be used as potential therapeutic agents for regenerative medicine due to their own repair function. Meanwhile, the natural predisposition toward inflammation or injury sites makes them promising carriers for targeted drug delivery. Inorganic nanoparticles (INPs) are greatly favored for their unique properties and potential applications in biomedical fields. Current research has integrated INPs with MSCs to enhance their regenerative or antitumor functions. This model also allows the in vivo fate tracking of MSCs in multiple imaging modalities, as many INPs are also excellent contrast agents. Thus, INP-integrated MSCs would be a multifunctional biologic agent with great potential. In this review, the current roles performed by the integration of INPs with MSCs, including (i) enhancing their repair and regeneration capacity via the improvement of migration, survival, paracrine, or differentiation properties, (ii) empowering tumor-killing ability through agent loaded or hyperthermia, and (iii) conferring traceability are summarized. An introduction of INP-integrated MSCs for simultaneous treatment and tracking is also included. The promising applications of INP-integrated MSCs in future treatments are emphasized and the challenges to their clinical translation are discussed.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article